The Short Version
This claim is false. HRT does not significantly increase cancer risk in all women. The evidence shows risk varies greatly by HRT type, duration, age, and individual health history. Estrogen-only HRT does not increase breast cancer risk and may lower it in some groups. Combined HRT modestly increases breast cancer risk (~5 extra cases per 1,000 women). Ovarian cancer risk increases are small and diminishing. In February 2026, the FDA removed blanket breast cancer warnings from HRT labels, reflecting that risks are individualized, not universal.